Q2 2025 Earnings Call Transcript October 8, 2024 Accolade, Inc. beats earnings expectations. Reported EPS is $-0.3, ...

Personalized healthcare company Accolade Inc (NASDAQ:ACCD) stock is trading slightly higher after the company announced ...

On Tuesday, Accolade Inc (ACCD) stock saw a modest uptick, ending the day at $4.04 which represents a slight increase of $0.07 or 1.76% from the prior close of $3.97. The stock opened at $4.22 and ...

Barclays analyst Stephanie Davis maintained a Hold rating on Accolade (ACCD – Research Report) today and set a price target of $5.00.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Accolade (ACCD – Research Report) and Gilead ...

Shares in Accolade Inc (NASDAQ:ACCD) jumped after the company reported a narrower-than-expected loss and strong margin growth for the fiscal Q2 2025. The company’s shares jumped more than 15% in ...

Susan Flavin defeated breast cancer (and a broken back) to earn the coveted Abbott Six Star Medal for her marathon runs.

Shares in Accolade rose after the company reported a narrower second-quarter loss and higher revenue, beating analyst expectations. Shares were up 17% in premarket trading at $4.64.

SEATTLE (AP) — SEATTLE (AP) — Accolade, Inc. (ACCD) on Tuesday reported a loss of $23.9 million in its fiscal second quarter. The Seattle-based company said it had a loss of 30 cents per share.

Collaboration efforts between the Alliance Historical Society and the Alliance Preservation Society are off to an ...

A garment business tycoon, an owner of a local conglomerate, a celebrated local steel giant, a well-known bank and a woman ...

Arlington County officials are trumpeting a recent accolade that came to Alcova Heights Park. The county's Department of ...